Synthesis, Molecular Docking Study, and ADMET Properties of New Antimicrobial Quinazolinone and Fused Quinazoline Derivatives

References

• D. S. A. Haneen, R. S. Gouhar, H. E. Hashem, and A. S. A. Youssef, “Synthesis and Reactions of 4 H -3,1-Benzoxazin-4-One Derivative Bearing Pyrazolyl Moiety as Antimicrobial and Antioxidant Agents,” Synthetic Communications 49 (2019): 1–16. doi:10.1080/00397911.2019.1646288.
   Web of Science ®Google Scholar
• T. Gupta, A. Rohilla, A. Pathak, M. J. Akhtar, M. R. Haider, and M. S. Yar, “Current Perspectives on Quinazolines with Potent Biological Activities: A Review,” Synthetic Communications 48, no. 10 (2018): 1099–127. doi:10.1080/00397911.2018.1431282.
   Web of Science ®Google Scholar
• S. Y. Abbas, K. A. M. El-Bayouki, W. M. Basyouni, and E. A. Mostafa, “New Series of 4(3H)-Quinazolinone Derivatives: Syntheses and Evaluation of Antitumor and Antiviral Activities,” Medicinal Chemistry Research 27, no. 2 (2018): 571–82. doi:10.1007/s00044-017-2083-7.
   Web of Science ®Google Scholar
• A. A. M. Abdel-Aziz, L. A. Abou-Zeid, K. E. H. Eltahir, R. R. Ayyad, M. A. A. El-Sayed, and A. S. El-Azab, “Synthesis, anti-Inflammatory, Analgesic, COX-1/2 Inhibitory Activities and Molecular Docking Studies of Substituted 2-Mercapto-4(3 H)-Quinazolinones,” European Journal of Medicinal Chemistry 121 (2016): 410–21. doi:10.1016/j.ejmech.2016.05.066.
   PubMed Web of Science ®Google Scholar
• V. Alagarsamy, K. Chitra, G. Saravanan, V. R. Solomon, M. T. Sulthana, and B. Narendhar, “An Overview of Quinazolines: Pharmacological Significance and Recent Developments,” European Journal of Medicinal Chemistry 151 (2018): 628–85. doi:10.1016/j.ejmech.2018.03.076.
   PubMed Web of Science ®Google Scholar
• V. Alagarsamy, and U. S. Pathak, “Synthesis and Antihypertensive Activity of Novel 3-Benzyl-2-Substituted-3H-[1,2,4]triazolo[5,1-b]quinazolin-9-Ones,” Bioorganic & Medicinal Chemistry 15, no. 10 (2007): 3457–62. doi:10.1016/j.bmc.2007.03.007.
   PubMed Web of Science ®Google Scholar
• A. Jabar, Kh. Atia, and S. S. Al-Mufrgeiy, “Synyhesis and Antibacterial Activities of New 3-Amino-2-Methyl-Quinazolin-4 (3h)-One Derivatives,” American Journal of Chemistry 2, no. 3 (2012): 150–6. doi:10.5923/j.chemistry.20120203.09.
   Google Scholar
• M. Mishra, V. K. Mishra, P. Senger, A. K. Pathak, and S. K. Kashaw, “Exploring QSAR Studies on 4-Substituted Quinazoline Derivatives as Antimalarial Compounds for the Development of Predictive Models,” Medicinal Chemistry Research 23, no. 3 (2014): 1397–405. doi:10.1007/s00044-013-0744-8.
   Web of Science ®Google Scholar
• A. Aboelmagd, E. M. S. Salem, I. A. I. Ali, and M. S. Gomaa, “Synthesis of Quinazolindionyl Amino Acid and Dipeptide Derivatives as Possible Antitumour Agents,” Arkivoc 2019, no. 6 (2019): 27–35. doi:10.24820/ark.5550190.p010.926.
   Google Scholar
• M. C. Tseng, H. Y. Yang, and Y. H. Chu, “Total Synthesis of Asperlicin C, Circumdatin F, Demethylbenzomalvin A, Demethoxycircumdatin H, Sclerotigenin, and Other Fused Quinazolinones,” Organic & Biomolecular Chemistry 8, no. 2 (2010): 419–27. doi:10.1039/b910545j.
   PubMed Web of Science ®Google Scholar
• A. S. A. Youssef, M. M. Hemdan, F. A. El-Mariah, and H. E. Hashem, “Synthesis of Some Quinazolinone Derivatives Functionalized with N-3 Heterocyclic Side Chain,” Journal of Heterocyclic Chemistry 55, no. 7 (2018): 1626–33. doi:10.1002/jhet.3197.
   Web of Science ®Google Scholar
• M. H. Hekal, F. S. M. Abu El-Azm, and S. R. Atta-Allah, “Ecofriendly and Highly Efficient Microwave-Induced Synthesis of Novel Quinazolinone-Undecyl Hybrids with in Vitro Antitumor Activity,” Synthetic Communications. 49, no. 20 (2019): 2630–41. doi:10.1080/00397911.2019.1637001.
   Web of Science ®Google Scholar
• M. A. E.-A. El-Hashash, M. E. Azab, R. A. E.-A. Faty, and A. E.-G. E. Amr, “Synthesis, Antimicrobial and anti-Inflammatory Activity of Some New Benzoxazinone and Quinazolinone Candidates,” Chemical & Pharmaceutical Bulletin 64, no. 3 (2016): 263–71. doi:10.1248/cpb.c15-00904.
   PubMed Web of Science ®Google Scholar
• S. Lakshmanan, D. Govindaraj, N. Ramalakshmi, and S. A. Antony, “Synthesis, Molecular Docking, DFT Calculations and Cytotoxicity Activity of Benzo[g]Quinazoline Derivatives in Choline Chloride-Urea,” Journal of Molecular Structure 1150 (2017): 88–95. doi:10.1016/j.molstruc.2017.08.082.
   Web of Science ®Google Scholar
• M. El-Saadi, N. Amin, S. Zaki, and H. Abdelrahman, “Abdel-Rahman, Synthesis, Docking and Biological Evaluation of 2,4-Disubstituted Quinazolines with Multi-Target Activities as anti-Cancer and Antimicrobial Agents,” Egyptian Journal of Chemistry 0, no. 0 (2020): 0–3734. doi:10.21608/ejchem.2020.23300.2385.
   Google Scholar
• W. Pao, and V. A. Miller, “Epidermal Growth Factor Receptor Mutations, Small-Molecule Kinase Inhibitors, and Non-Small-Cell Lung Cancer: Current Knowledge and Future Directions,” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23, no. 11 (2005): 2556–68. doi:10.1200/JCO.2005.07.799.
   PubMed Web of Science ®Google Scholar
• C. M. Dixon, J. W. Kusek, D. Ph, H. Lepor, K. T. Mcvary, L. M. Nyberg, D. Ph, H. S. Clarke, D. Ph, E. D. Crawford, A. Diokno, J. P. Foley, H. E. Foster, S. C. Jacobs, S. A. Kaplan, K. J. Kreder, M. M. Lieber, M. S. Lucia, G. J. Miller, D. Ph, M. Menon, D. F. Milam, J. W. Ramsdell, N. S. Schenkman, K. M. Slawin, “The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia,” N. Engl. J. Med. 349 (2003) 2387–2398
   Google Scholar
• Z. A. Khan, S. A. R. Naqvi, S. A. Shahzad, N. Mahmood, M. Yar, and A. F. Zahoor, “Synthesis and Antimicrobial Activity of 2-Aryl-4H-3,1-Benzoxazin-4-Ones,” Asian Journal of Chemistry 25, no. 1 (2013): 152–6. doi:10.14233/ajchem.2013.12846.
   Google Scholar
• A. El-Mekabaty, “Chemistry of 4 H -3, 1-Benzoxazin-4-Ones,” Int. J. Mod. Org. Chem 2 (2013): 81–121.
   Google Scholar
• M. Shariat, and S. Abdollahi, “Synthesis of Benzoxazinone Derivatives: A New Route to 2 (N phthaloylmethyl)-4H-3,1-benzoxazin-4-one,” Molecules (Basel, Switzerland) 9, no. 8 (2004): 705–12. doi:10.3390/90800705.
   PubMed Web of Science ®Google Scholar
• S. A. Rizk, “Utility of Azalactones in Synthesis of Some New Heterocyclic Compounds,” International Journal of Chemistry and Material Sciences 1 (2013): 189–94. http://academeresearchjournals.org/journal/ijcms.
   Google Scholar
• M. A. El-Hashash, and S. A. Rizk, “Behaviour of 4-(4-Acetylaminophenyl)-4-Oxobut-2-Enoic Acid towards Nucleophiles and Synthesis of Various N-Heterocycles,” European Chemical Bulletin 2 (2013): 456–60.
   Google Scholar
• El-Sayed I. El-Desoky, Eman M. Keshk, Aya A. El-Sawi, Mohamed A. Abozeid, Laila A. Abouzeid, and Abdel-Rahman H. Abdel-Rahman, “Abdel-Rahman, Synthesis, Biological Evaluation and in Silico Molecular Docking of Novel 1-Hydroxy-Naphthyl Substituted Heterocycles,” Saudi Pharmaceutical Journal: SPJ: The Official Publication of the Saudi Pharmaceutical Society 26, no. 6 (2018): 852–9. doi:10.1016/j.jsps.2018.03.013.
   PubMed Web of Science ®Google Scholar
• M. M. Hemdan, A. S. A. Youssef, F. A. El-Mariah, and H. E. Hashem, “Synthesis and Antimicrobial Assessments of Some Quinazolines and Their Annulated Systems,” Journal of Chemical Research 41 (2017): 106-111. doi:10.3184/174751917X14858862342269.
   Google Scholar
• E. Mavridis, E. Bermperoglou, E. Pontiki, and D. Hadjipavlou-Litina, “Their Benzamides as Potential Bioactive Small Molecules,” Molecules 25, no. 14 (2020): 3173. doi:10.3390/molecules25143173.
   PubMed Web of Science ®Google Scholar
• B. Sha, L. Hadian, and A. R. Khosropour, “RSC Advances an Innovation for Development of Erlenmeyer Plochl Reaction and Synthesis of at-130 Analogous: A New Application of Continuous- Flow Method†,” RSC Advances 6, no. 24 (2016): 19861–6. doi:10.1039/C6RA00301J.
   Web of Science ®Google Scholar
• H. E. Hashem, and A. M. Abo-Bakr, “Synthesis of Some New 1,2,4-Triazine and 1,2,5-Oxadiazine Derivatives with Antimicrobial Activity,” Heteroatom Chemistry 2019 (2019): 1–7. 10.1155/2019/2326514.
   Web of Science ®Google Scholar
• H. E. Hashem, A. E.-G. E. Amr, E. S. Nossier, E. A. Elsayed, and E. M. Azmy, “Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors,” Molecules 25, no. 12 (2020): 2766. doi:10.3390/molecules25122766.
   PubMed Web of Science ®Google Scholar
• I. M. M. Othman, M. A. M. Gad-Elkareem, M. El-Naggar, E. S. Nossier, and A. E. G. E. Amr, “Novel Phthalimide Based Analogues: design, Synthesis, Biological Evaluation, and Molecular Docking Studies,” Journal of Enzyme Inhibition and Medicinal Chemistry 34, no. 1 (2019): 1259–70. doi:10.1080/14756366.2019.1637861.
   PubMed Web of Science ®Google Scholar
• M. A. El-Hashash, A. M. El-Metwally, A. M. F. Eissa, and A. M. F. El-Gohary, “Synthesis and Biological Evaluation of Some New 4(3H)-Quinazolinone Derivatives as Non-Classical Antifolate,” Egyptian Journal of Chemistry 53 (2010): 777–90.
   Google Scholar
• R. R. Nasab, F. Hassanzadeh, G. A. Khodarahmi, M. Mirzaei, M. Rostami, and A. J. N. Abadi, “Synthesis, Characterization, Cytotoxic Screening, and Density Functional Theory Studies of New Derivatives of Quinazolin-4(3H)-One Schiff Bases,” Research in Pharmaceutical Sciences 12, no. 6 (2017): 444–55. doi:10.4103/1735-5362.217425.
   PubMedGoogle Scholar
• M. Sarkar, A. Nath, A. Kumer, C. Mallik, F. Akter, Md Moniruzzaman, and Md A. Ali, “Synthesis, Molecular Docking Screening, ADMET and Dynamics Studies of Synthesized 4-(4-Methoxyphenyl)-8-Methyl-3,4,5,6,7,8-Hexahydroquinazolin-2(1H)-One and Quinazolinone Derivatives,” Journal of Molecular Structure 1244 (2021): 130953. doi:10.1016/j.molstruc.2021.130953.
   Web of Science ®Google Scholar
• A. A. El-Sayed, M. F. Ismail, A. E. E. Amr, and A. M. Naglah, “Synthesis, Antiproliferative, and Antioxidant Evaluation of 2-Pentylquinazolin-4(3H)-One(Thione) Derivatives with DFT Study,” Molecules 24, no. 20 (2019): 3787–19. doi:10.3390/molecules24203787.
   PubMed Web of Science ®Google Scholar
• S. Tian, J. Wang, Y. Li, D. Li, L. Xu, and T. Hou, “The Application of in Silico Drug-Likeness Predictions in Pharmaceutical Research,” Advanced Drug Delivery Reviews 86 (2015): 2–10. doi:10.1016/j.addr.2015.01.009.
   PubMed Web of Science ®Google Scholar
• A. Nath, A. Kumer, F. Zaben, and W. Khan, “Investigating the Binding Affinity, Molecular Dynamics, and ADMET Properties of 2, 3-Dihydrobenzofuran Derivatives as an Inhibitor of Fungi, Bacteria, and Virus Protein, Beni-Suef Univ,” Journal of Basic and Applied Scientific Research 10 (2021): 1–13. doi:10.1186/s43088-021-00117-8.
   Google Scholar
• A. Kumar, S. Divya, S. Bijoy, and K. Roy, “Structural Interactions of Curcumin Biotransformed Molecules with the N-Terminal Residues of Cytotoxic-Associated Gene a Protein Provide Insights into Suppression of Oncogenic Activities,” Interdisciplinary Sciences, Computational Life Sciences 9, no. 1 (2017): 116–29. doi:10.1007/s12539-016-0142-2.
   PubMed Web of Science ®Google Scholar
• A. K. Srivastava, Mallika. Tewari, Hari S. Shukla, and Bijoy K. Roy, “In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation,” Archiv Der Pharmazie 348, no. 8 (2015): 548–55. doi:10.1002/ardp.201400438.
   PubMed Web of Science ®Google Scholar